As the process of biomanufacturing continues to advance, effective, high-quality cell line development (CLD) remains essential for success. The key to minimizing risk and optimizing positive outcomes in having a reliable partner that offers experience, expertise, and a comprehensive portfolio of products and services for a modernized workflow. This presentation will highlight key challenges and considerations during biopharmaceutical CLD and the impact early decision-making can have at later stages of the development process.